Here's some speculation on why CRC moved to the to
Post# of 147931
It was my understanding that the MD Anderson murine study results had not been disclosed to CYDY because they hadn't paid the required monies to obtain the results. I'm guessing that perhaps they paid and got the results, and they were strong, hence the new priority. If this is the case, then Merck would likely be the partner.